Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIFT-AHF early ivabradine trial in acute decompensated heart failure
ChiCTR2000029836Phase 4Not yet recruiting
- Sponsor
- Shanghai Tenth People's Hospital
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ivabradine in heart failure (HF) (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoints: All-cause mortality and Readmission caused by heart failure. Planned start Mar 2020; status: not yet recruiting.
02
Drugs
ivabradine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ChiCTR2000029836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029836.